Ads
related to: Treatment Pah- What Is PAH?
Pulmonary Arterial Hypertension Is
A Progressive Disease. Learn More.
- Prostacyclin Therapy
Learn About A Pathway That May
Impact Prognostic Measures Of Risk.
- PAH Treatment Guidelines
Get PAH Disease State Education &
Resources. No Product Promotion.
- PAH Risk Calculators
Easy-To-Use Online Tools To Help
Predict 5 Year Prognosis.
- REVEAL 2.0 PAH Calculator
Use WHO Group, Demographics, BNP, &
More To Help Calculate Risk Status.
- French Non-Invasive
Use WHO FC, 6MWD, & NT-proBNP To
Help Predict 5 Year Prognosis.
- What Is PAH?
Search results
Her PAH Symptoms Were Getting Worse. Then She Joined a Clinical Trial
Healthline· 4 days agoPulmonary arterial hypertension (PAH) is a condition that causes a narrowing of the blood vessels in...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 10 hours agoThe company is working on a drug to treat liver fibrosis due to hepatitis B and metabolic...
Inhibikase Therapeutics progresses in Parkinson's disease trials By Investing.com
Investing.com· 1 day agoInhibikase Therapeutics, Inc. (NASDAQ:IKT), a pharmaceutical company engaged in developing ...
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
Morningstar· 1 day agoInhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's ...
Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights By Investing.com
Investing.com· 4 days agoReviva Reports Full Year 2023 Financial Results and Recent Business Highlights
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript Highlights: Navigating Market ...
GuruFocus.com via Yahoo Finance· 3 days agoA: Jennifer Taubert mentioned that both Opsumit and Uptravi delivered strong growth due to volume, share gains, and favorable patient mix. She also highlighted the approval of Upsinbi, the first ...
Russell Schundler Sells 2,060 Shares of Liquidia Co. (NASDAQ:LQDA) Stock
ETF DAILY NEWS· 18 hours agoLiquidia Co. (NASDAQ:LQDA – Get Free Report) General Counsel Russell Schundler sold 2,060 shares of the business’s stock in a transaction on Friday, April 12th. The shares were sold at an average ...
Liquidia Co. (NASDAQ:LQDA) Insider Sells $17,335.62 in Stock
ETF DAILY NEWS· 2 days agoLiquidia Co. (NASDAQ:LQDA – Get Free Report) insider Jason Adair sold 1,189 shares of Liquidia stock in a transaction dated Friday, April 12th. The shares were sold at an average price of $14.58 ...
Liquidia Co. (NASDAQ:LQDA) Stock Holdings Increased by SG Americas Securities LLC
ETF DAILY NEWS· 6 days agoSG Americas Securities LLC boosted its position in Liquidia Co. (NASDAQ:LQDA – Free Report) by 17.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the ...
Ads
related to: Treatment Pah
